Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?
Journal: European journal of neurology
Published: August 12, 2024
Recognition, Description, and Variability of Spasticity in Individuals With Multiple Sclerosis and Potential Barriers to Clinician-Patient Dialogue: Results From SEEN-MSS, a Large-Scale, Self-Reported Survey.
Journal: International journal of MS care
Published: March 14, 2024
Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative Review.
Journal: Neurology and therapy
Published: September 06, 2023
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab.
Journal: Multiple sclerosis and related disorders
Published: April 06, 2023
The Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis by Disease Severity.
Journal: Journal of health economics and outcomes research
Published: August 31, 2022
Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported survey.
Journal: Multiple sclerosis and related disorders
Published: May 30, 2022
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).
Journal: CNS drugs
Published: April 28, 2021
Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era.
Journal: Multiple sclerosis and related disorders
Published: December 11, 2020
An international discrete choice experiment assessing patients' preferences for disease-modifying therapy attributes in multiple sclerosis.
Journal: Neurodegenerative disease management
Published: September 03, 2020
Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.
Journal: Patient preference and adherence
Published: July 28, 2018
Peginterferon beta-1a for the treatment of relapsing multiple sclerosis: A case series.
Journal: Multiple sclerosis and related disorders
Published: June 06, 2018
Last Updated: 09/26/2026